Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma

International Journal of Oncology

Volumn 41, Issue 2, 2012, Pages 573-582

  Okamoto, Koichi ^a   Tajima, Hidehiro ^a   Nakanuma, Shinichi ^a   Sakai, Seisho ^a   Makino, Isamu ^a   Kinoshita, Jun ^a   Hayashi, Hironori ^a   Nakamura, Keishi ^a   Oyama, Katsunobu ^a   Nakagawara, Hisatoshi ^a   Fujita, Hideto ^a   Takamura, Hiroyuki ^a   Ninomiya, Itasu ^a   Kitagawa, Hirohisa ^a   Fushida, Sachio ^a   Fujimura, Takashi ^a   Harada, Shinichi ^a   Wakayama, Tomohiko ^a   Iseki, Shoichi ^a   Ohta, Tetsuo ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Angiotensin II; CXCR4; Epithelial to mesenchymal transition; Hepatic stellate cell; Stromal cell derived factor 1

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; BETA CATENIN; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; UVOMORULIN; VIMENTIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL ACTIVATION; CELL INTERACTION; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; DISTANT METASTASIS; EPITHELIAL MESENCHYMAL TRANSITION; FIBROGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STELLATE CELL; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN II; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; CHOLANGIOCARCINOMA; COCULTURE TECHNIQUES; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; HEPATIC STELLATE CELLS; HUMANS; LINEAR MODELS; MIDDLE AGED; PROGNOSIS; RECEPTORS, CXCR4;

EID: 84863562352     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1499     Document Type: Article

References (45)

1. Teicher BA and Fricker SP: CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16: 2927-2931, 2010.
2. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL and Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005. (Pubitemid 40692295)
3. Ohira S, Sasaki M, Harada K, Sato Y, Zen Y, Isse K, Kozaka K, Ishikawa A, Oda K, Nimura Y and Nakanuma Y: Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-α and stromal-derived factor-1 released in stroma. Am J Pathol 168: 1155-1168, 2006.
4. Marchesi F, Monti P, Leone BE, Zerbi A, Vecchi A, Piemonti L, Mantovani A and Allavena P: Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 64: 8420-8427, 2004. (Pubitemid 39491782)
5. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW and Banerjee D: Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339, 2008.
6. Okamoto K, Tajima H, Ohta T, Nakanuma S, Hayashi H, Nakagawara H, Ohishi I, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Tani T, Fujimura T, Kayahara M, Harada S, Wakayama T and Iseki S: Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells. Int J Oncol 37: 1251-1259, 2010.
7. Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ and Arafat HA: Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. J Gastrointest Surg 12: 57-66, 2008.
8. Amann T, Bataille F, Spruss T, Mühlbauer M, Gäbele E, Schölmerich J, Kiefer P, Bosserhoff AK and Hellerbrand C: Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100: 646-653, 2009.
9. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
10. Buck E, Eyzaguirre A, Barr S, Thompson S, Sennello R, Young D, Iwata KK, Gibson NW, Cagnoni P and Haley JD: Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Mol Cancer Ther 6: 532-541, 2007. (Pubitemid 46332455)
11. Thompson EW, Newgreen DF and Tarin D: Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65: 5991-5995, 2005. (Pubitemid 40994377)
12. Valcourt U, Kowanetz M, Niimi H, Heldin CH and Moustakas A: TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 16: 1987-2002, 2005. (Pubitemid 40471965)
13. Elliott BE, Hung WL, Boag AH and Tuck AB: The role of hepatocyte growth factor (scatter factor) in epithelial mesenchymal transition and breast cancer. Can J Physiol Pharmacol 80: 91-102, 2002. (Pubitemid 34258657)
14. Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W, Somcio R, Bauer TW, Wu Y, Hicklin DJ and Ellis LM: Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res 66: 46-51, 2006. (Pubitemid 43166007)
15. Rosanò L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, De Herreros AG, Natali PG and Bagnato A: Endothelin-1 promotes epithelial-to- mesenchymal transition in human ovarian cancer cells. Cancer Res 65: 11649-11657, 2005. (Pubitemid 41821725)
16. Andl CD, Fargnoli BB, Okawa T, Bowser M, Takaoka M, Nakagawa H, Klein-Szanto A, Hua X, Herlyn M and Rustgi AK: Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo. Cancer Res 66: 9878-9885, 2006. (Pubitemid 44672039)
17. Chen J, Chen JK and Harris RC: Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through ROS/ Src/Caveolin-mediated activation of an EGFR-ERK signaling pathway. Mol Cell Biol 32: 981-991, 2012.
18. Chang J, Jiang Z, Zhang H, Zhu H, Zhou SF and Yu X: NADPH oxidase-dependent formation of reactive oxygen species contributes to angiotensin II-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells. Int J Mol Med 28: 405-412, 2011.
19. Buckley ST, Medina C and Ehrhardt C: Differential susceptibility to epithelial-mesenchymal transition (EMT) of alveolar, bronchial and intestinal epithelial cells in vitro and the effect of angiotensin II receptor inhibition. Cell Tissue Res 342: 39-51, 2010.
20. Liver Cancer Study Group of Japan: The general rules for the clinical and pathological study of primary liver cancer. 5th edition. Kanehara, Tokyo, pp17-27, 2008.
21. Morimoto T, Aoyama M, Gotoh E and Shionoiri H: A method of radioimmunoassay of plasma angiotensin II using Florisil. Folia Endocrinoa Jpn 59: 215-229, 1983. (Pubitemid 13052604)
22. Miyagiwa M, Ichida T, Tokiwa T, Sato J and Sasaki H: A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium. In Vitro Cell Dev Biol 25: 503-510, 1989. (Pubitemid 19177403)
23. Sugawara H, Yasoshima M, Katayanagi K, Kono N, Watanabe Y, Harada K and Nakanuma Y: Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma. Histopathology 33: 145-153, 1998. (Pubitemid 28387024)
24. Murakami K, Abe T, Miyazawa M, Yamaguchi M, Masuda T, Matsuura T, Nagamori S, Takeuchi K, Abe K and Kyogoku M: Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells. Lab Invest 72: 731-739, 1995.
25. Salguero Palacios R, Roderfeld M, Hemmann S, Rath T, Atanasova S, Tschuschner A, Gressner OA, Weiskirchen R, Graf J and Roeb E: Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice. Lab Invest 88: 1192-1203, 2008.
26. Gressner AM and Weiskirchen R: Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J Cell Mol Med 10: 76-99, 2006. (Pubitemid 44874293)
27. Tien YW, Wu YM, Lin WC, Lee HS and Lee PH: Pancreatic carcinoma cells stimulate proliferation and matrix synthesis of hepatic stellate cells. J Hepatol 51: 307-314, 2009.
28. Okabe H, Beppu T, Hayashi H, Horino K, Masuda T, Komori H, Ishikawa S, Watanabe M, Takamori H, Iyama K and Baba H: Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. Ann Surg Oncol 16: 2555-2564, 2009.
29. Leelawat K, Leelawat S, Narong S and Hongeng S: Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion. World J Gastroenterol 13: 1561-1568, 2007. (Pubitemid 46672665)
30. Gilles C and Thompson EW: The epithelial to mesenchymal transition and metastatic progression in carcinoma. Breast J 2: 83-96, 1996.
31. Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, Ruhland C, Adler G and Gress TM: Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 61: 4222-4228, 2001. (Pubitemid 32720992)
32. Peinado H, Portillo F and Cano A: Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48: 365-375, 2004. (Pubitemid 39360388)
33. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ and Schalken JA: Cadherin switching in human prostate cancer progression. Cancer Res 60: 3650-3654, 2000. (Pubitemid 30482189)
34. Rodrigues-Díez R, Carvajal-González G, Sánchez- López E, Rodríguez-Vita J, Rodrigues Díez R, Selgas R, Ortiz A, Egido J, Mezzano S and Ruiz-Ortega M: Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. Pharm Res 25: 2447-2461, 2008.
35. Ruiz-Ortega M, Rupérez M, Esteban V, Rodríguez-Vita J, Sánchez-López E, Carvajal G and Egido J: Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21: 16-20, 2006. (Pubitemid 43057101)
36. Carvajal G, Rodríguez-Vita J, Rodrigues-Díez R, Sánchez-López E, Rupérez M, Cartier C, Esteban V, Ortiz A, Egido J, Mezzano SA and Ruiz-Ortega M: Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int 74: 585-595, 2008.
37. Wolf G: Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70: 1914-1919, 2006.
38. Bakin AV, Rinehart C, Tomlinson AK and Arteaga CL: p38 mitogen-activated protein kinase is required for TGFbeta mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 115: 3193-3206, 2002.
39. Rupérez M, Lorenzo O, Blanco-Colio LM, Esteban V, Egido J and Ruiz-Ortega M: Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 108: 1499-1505, 2003. (Pubitemid 37176458)
40. Moustakas A and Heldin CH: Non-Smad TGF-beta signals. J Cell Sci 118: 3573-3584, 2005.
41. Ruiz-Ortega M, Rodríguez-Vita J, Sanchez-Lopez E, Carvajal G and Egido J: TGF-beta signaling in vascular fibrosis. Cardiovasc Res 74: 196-206, 2007.
42. Lee BC, Lee TH, Avraham S and Avraham HK: Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2: 327-338, 2004. (Pubitemid 39025295)
43. Onoue T, Uchida D, Begum NM, Tomizuka Y, Yoshida H and Sato M: Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. Int J Oncol 29: 1133-1138, 2006.
44. Ishii G, Sangai T, Ito T, Hasebe T, Endoh Y, Sasaki H, Harigaya K and Ochiai A: In vivo and in vitro characterization of human fibroblasts recruited selectively into human cancer stroma. Int J Cancer 117: 212-220, 2005. (Pubitemid 41377440)
45. Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.